Baxter International Inc. Recalling intravenous (IV) Solutions


Recall Number: #584174bf05
Date Published: July 16, 2014
Manufacturer: Baxter International Inc

Hazards

Inflammatory and allergic responses (may be life threatening)

Summary by USRecalls.org

Baxter International Inc. has issued a voluntarily recall of four lots of intravenous (IV) solutions. These lots of IV have been found to contain particulate matter identified as cellulosic fibers and/or plastics. If administered the particulate foreign matter can produce an inflammatory and allergic reaction.

FDA Official Description

Baxter International Inc. announced today it is voluntarily recalling four lots of intravenous (IV) solutions to the hospital/user level. These products have been found to contain particulate matter identified as cellulosic fibers and/or plastics. Baxter received four complaints over a period of six months from customers whose visual inspection identified the appearance of visible particulate matter prior to administration to a patient.

Products Affected

Product Code 2B1302 Description 0.9% Sodium Chloride 100 mL (Quad Pack) Lot # P298190 Exp. Date Aug 2014 NDC 0338-0049-18 Product Code 2B0043 Description 0.9% Sodium Chloride 100 mL MINI-BAG Plus Lot # P308650 Exp. Date Oct 2014 NDC 0338-0553-18 Product Code 2B1306 Description 0.9% Sodium Chloride, 50 mL (Single Pack) Lot # P309187 Exp. Date Oct 2014 NDC 0338-0049-41 Product Code 2B0822 Description Highly Concentrated Potassium Chloride Injection, 20 mEq/50 mL, VIAFLEX Plus Container Lot # P309476Exp. Date Oct 2014 NDC 0338-0703-41

What do I do next?

Baxter has notified customers who may be in possession of the recalled IV lots. Customers should not to use recalled products and should be return the affected product to Baxter for credit by contacting Baxter Healthcare Center for Service at 1-888-229-0001, Monday through Friday, between the hours of 7:00 a.m. and 6:00 p.m., Central.